Form D · Pharmaceuticals
RECEPTOR HOLDINGS, INC.
Seattle, WA · CIK 0001757296
Offering snapshot reported Dec 21, 2021 · SEC filing
- Reported sold
- $7.3M Offering amount: $10M
- Investors reported
- 45 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 6, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 21, 2021 | Initial | $7,299,313 | No comparison | 45 | SEC filing |
| Oct 29, 2018 | Initial | $28,876,978 | No comparison | 75 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-426197
Series A-1 Preferred Stock
Source: Form D, filed Dec 21, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Traci Carman | Executive, Promoter |
| Orrin Devinsky, Md, Ph D | Director |
| Stephen Hoffman, Md, Ph D | Director |
| Warren Lammert | Director |
| Andrea Leone Bay | Executive, Promoter |
| Gregory Mayes | Director |
| Arthur Rubinfeld | Director |
| Mark Theeuwes | Director, Executive, Promoter |
| Jim Weissman | Director |
| Greg Wesner | Director |
| Gregory Wesner | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1200 Fifth Avenue, Suite 1400
Seattle, WA, 98101
Seattle, WA, 98101